Press Releases

With This Approval 25 States Have Approved Transaction

-- 2019 Third Quarter Diluted EPS of $0.23; Adjusted Diluted EPS of $0.96 --

With These Approvals 24 States Have Approved Transaction

The additional region includes 14 counties and the capital city of Raleigh

Christopher Bowers to Retire and Continue as a Consultant to the Company

Announces Additional State Approvals with California and Wisconsin

17 States Have Approved Transaction

-- 2019 Second Quarter Diluted EPS of $1.18; Adjusted Diluted EPS of $1.34 --

Companies Provide Update on State Regulatory Approval Process

Centene to Preview Additional Details of Organizational Structure for Combined Company at Investor Day Scheduled for June 14, 2019

Transaction on Track to Close by First Half of 2020

-- 2019 First Quarter Diluted EPS of $1.24; Adjusted Diluted EPS of $1.39 --

Youth contest is part of Centene's national OpiEnd program to raise awareness about opioid misuse and prevention

Partnership to focus on Alzheimer's disease, breast cancer, diabetes, obesity

Transaction Valued at $17.3 Billion Combined Company to Have Approximately 22 Million Members Across All 50 States Increased Scale and Leading Medicare Platform Enhances Growth Transaction Projected to Be Mid-Single Digit Accretive to Adjusted EPS in Year Two Companies to Host Conference Call at 8:00 AM ET

- Live Audio Webcast of Annual Meeting Available - - Reminder: June 14, 2019 Investor Day and 2019 Quarterly Earnings Release Dates in Usual Pattern -

-- 2018 Full Year Diluted EPS of $4.52; Adjusted Diluted EPS of $7.08 --

Joint Venture to Offer Unique Approach to Medicaid Reform in North Carolina